CSE: SONA | OTCQB: SNANF
+1-902-442-0653
Purdy’s Wharf Tower II Suite 2001 – 1969 Upper Water Street
Home
Science
Technology Overview
Targeted Hyperthermia Therapy
Scientific Evidence
Pipeline
Investors
Share Information
Investor Presentation
Research Coverage
Financial Reports
News & Media
News Releases
Carman’s Corner
Media Centre
Insights
About
Our Story
Leadership
Board of Directors
Advisory Board
Subscribe
Sona Nanotech Receives ‘Deprioritization’ from FDA; Health Canada Evaluation Continues
October 29, 2020
News Releases
← All News Releases
News Release
October 29, 2020
Sona Nanotech Receives ‘Deprioritization’ from FDA; Health Canada Evaluation Continues
Author
Wynand van Niekerk
Share:
in
X
✉
Home
Science
Technology Overview
Targeted Hyperthermia Therapy
Scientific Evidence
Pipeline
Investors
Share Information
Investor Presentation
Research Coverage
Financial Reports
News & Media
News Releases
Carman’s Corner
Media Centre
Insights
About
Our Story
Leadership
Board of Directors
Advisory Board
Subscribe
